Skip to content

02575.HK

Xuanzhubio-b

HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN

HKD 10.43
−6.21%
Ask drillr

Income statement

Metric2025202420232022
Revenue
Total Revenue56.1M32.6M32.0K
Cost of Revenue34.4M45.2M35.6M30.2M
Gross Profit21.8M(12.6M)(35.5M)(30.2M)
Operating Expenses
R&D Expense120.3M180.9M238.7M444.9M
SG&A Expense146.3M413.0M95.6M100.4M
General & Admin Expense
Selling & Marketing Expense
Other Expenses8.3M4.7M4.8M4.7M
Total Operating Expenses274.9M598.7M339.2M550.1M
Cost and Expenses309.3M643.9M374.7M580.2M
Operating Income (EBIT)(253.1M)(611.3M)(374.7M)(580.2M)
Non-Operating
Interest Income7.4M7.2M15.9M27.6M
Interest Expense134.5K329.6K1.3M1.8M
Net Interest Income7.2M6.9M14.6M25.9M
Other Non-Op Income/Expense(13.1M)8.0M42.6M(15.5M)
Non-Operating Income (excl Interest)(8.3M)(43.9M)13.7M
EBT (Pre-Tax Income)(266.3M)(603.3M)(332.1M)(595.7M)
Income Tax Expense6.5K6.5K6.6K5.8K
Bottom Line
Net Income(266.3M)(603.3M)(332.1M)(595.7M)
Earnings from Cont. Ops(266.3M)(603.3M)(332.1M)(595.7M)
Earnings from Discont. Ops
Bottom Line Net Income(266.3M)(603.3M)(332.1M)(595.7M)
Per Share
Basic EPS(HK$0.51)(HK$1.16)(HK$0.64)(HK$1.15)
Diluted EPS(HK$0.51)(HK$1.16)(HK$0.64)(HK$1.15)
Revenue Per ShareHK$0.11HK$0.06HK$0.00HK$0.00
Shares
Basic Shares Outstanding517.9M517.9M517.9M517.9M
Diluted Shares Outstanding517.9M517.9M517.9M517.9M
Profitability Metrics
EBITDA(220.5M)(566.4M)(295.3M)(563.8M)
D&A32.6M36.6M35.5M30.2M
EBIT(253.1M)(603.0M)(330.8M)(593.9M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Dec 1, 2025